1. Home
  2. BCRX vs SHAZ Comparison

BCRX vs SHAZ Comparison

Compare BCRX & SHAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$9.95

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo SharonAI Holdings Inc. Class A Common Stock

SHAZ

SharonAI Holdings Inc. Class A Common Stock

N/A

Current Price

$55.48

Market Cap

2.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BCRX
SHAZ
Founded
1986
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
BCRX
SHAZ
Price
$9.95
$55.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$20.82
$46.67
AVG Volume (30 Days)
2.9M
1.7M
Earning Date
05-06-2026
06-23-2026
Dividend Yield
N/A
N/A
EPS Growth
381.40
N/A
EPS
N/A
N/A
Revenue
$25,186,000.00
$1,566,631.00
Revenue This Year
N/A
$8,711.27
Revenue Next Year
$12.55
$587.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
257.44
52 Week Low
$6.00
$16.55
52 Week High
$11.22
$97.48

Technical Indicators

Market Signals
Indicator
BCRX
SHAZ
Relative Strength Index (RSI) 55.95 43.60
Support Level $8.79 $47.51
Resistance Level $10.32 $77.92
Average True Range (ATR) 0.32 5.46
MACD 0.02 -0.79
Stochastic Oscillator 81.17 15.67

Price Performance

Historical Comparison
BCRX
SHAZ

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About SHAZ SharonAI Holdings Inc. Class A Common Stock

SharonAI Holdings Inc is a neocloud operator, purpose-built to power the next generation of artificial intelligence (AI) and high-performance computing (HPC). The Company's infrastructure is architected from the ground up to meet the specific, intensive, and complex demands of modern AI training and inference workloads, machine learning, and Generative AI. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, and SHARON AI Studio. The company's products are: SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, and Machine Learning & Infrastructure. The Company operates in one operating segment, High Performance Compute Services (HPC).

Share on Social Networks: